*Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands;
†Louvain Centre for Toxicology and Applied Pharmacology (LTAP) Department, Université catholique de Louvain, Brussels, Belgium;
‡Department of Internal Medicine and
§Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands;
¶Department of Nephrology, Charite University, Berlin, Germany;
‖Department of Nephrology, Leiden University Medical Centre, Leiden, the Netherlands;
**Surgery and Abdominal Transplantation Unit Cliniques universitaires St Luc, Université catholique de Louvain, Brussels, Belgium; and
††Department of Nephrology, University of Leuven, Leuven, Belgium.
Correspondence: Ron H. N. van Schaik, PhD, Department of Clinical Chemistry, Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, the Netherlands (e-mail: [email protected]).
The authors declare no conflicts of interest.
Dr D.A.H. has received lecture fees and grant support from Astellas Pharma Inc.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.drug-monitoring.com).
Received November 12, 2012
Accepted May 27, 2013
